Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Algernon Pharmaceuticals Inc Class A (AGN)

CSE
Currency in CAD
Disclaimer
0.105
0.000(0.00%)
Delayed Data

AGN Comments

Big news comin soon! Buckle up
why we going down again?
If you have already invested, then stay put.  Otherwise, it's a wait and see over the next 3 -6 months until positive results start moving towards some proven results which will ultimately lead to sales traction in various markets around the world.  No, a vaccine created in the UK, US or otherwise will not be the killer of ifenprodil treatments worldwide.  Expect to see above .50 and beyond for end of March of 2021.
How about now?
Anybody on the fence better load up now...
Anybody on the fence better load up now...
09:30 Wed 05 Aug 2020Algernon says first patient dosed in Phase 2 study of Ifenprodil as a treatment in idiopathic pulmonary fibrosis and chronic cough
Gonna pass 50 cents with new positive results soon
This companies full of shit
Algernon is starting to appear as a hidden gem among traditional BioTech 'buy and hope' purchases by the public.  Ifenprodil has been proven in the past, and is gaining more attention as a leading runner for 'treatment' of Covid-19 versus wishful thinking for a near term Vaccine/Cure.  Positive support for investigative trials in South Korea, Australia, Canada, and now the US is warming up as well.  Management has a strong position of awareness of the future outlook and complexities of the upcoming trials.  Minimum 6 month position recommended, with 12-18 months more realistic of expectations of turning a healthy return on your investment.  If you have the patience for the medium term, this could provide you with exceptional returns.
How can they say they are cautioning that Ifenprodil is not expresing to treat covid 19 when they testing it to treat it....
They got FDA clearance for Ifenprodil study
My does my stock say 0.03 on portfolio but the stock is currently .34
Mine also does. I nearly shit!
whats going on haha
My qtrade has corrected. Maybe a smallGlich
Any recient news?
Great buy, Covid study heating up and phase 2 for IPF plan and clinical study of its repurposed drug NP-120 is now approved in Australia.
Good opportunity to buy again!
health canada gives a green light...woohooo
Where did you read this?
on proactive investors website
Thanks
BUY!! BIG BUY!!
hmmmm who's been in since .20
went in...phase 3 about to begin ...power moveee
Next week!
It's happening guys, Hopefully lots of good news next week
what do you think will become of there trials ? and will this stock be a money maker could we see this at 5 dollars anytime soon?
what do you guys think it's a strong Buy right now ?
What's happening with BTH
any news?
No nothing. I'm wondering if I should keep my shares with them
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.